{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:39:27Z","timestamp":1774442367835,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T00:00:00Z","timestamp":1606608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T00:00:00Z","timestamp":1606608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41417-020-00252-x","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T09:02:29Z","timestamp":1606640549000},"page":"693-705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression"],"prefix":"10.1038","volume":"28","author":[{"given":"Tao","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1949-4269","authenticated-orcid":false,"given":"Zongbu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,29]]},"reference":[{"key":"252_CR1","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3892\/ijo.2016.3347","volume":"48","author":"T Tadokoro","year":"2016","unstructured":"Tadokoro T, Morishita A, Fujihara S, Iwama H, Niki T, Fujita K, et al. Galectin-9: an anticancer molecule for gallbladder carcinoma. Int J Oncol. 2016;48:1165\u201374.","journal-title":"Int J Oncol"},{"key":"252_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003675","volume":"95","author":"JY Jang","year":"2016","unstructured":"Jang JY, Heo JS, Han Y, Chang J, Kim JR, Kim H, et al. Impact of type of surgery on survival outcome in patients with early gallbladder cancer in the era of minimally invasive surgery: oncologic safety of laparoscopic surgery. Med (Baltim). 2016;95:e3675.","journal-title":"Med (Baltim)"},{"key":"252_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijmedinf.2016.11.005","volume":"98","author":"S Atanasova","year":"2017","unstructured":"Atanasova S, Kamin T, Petric G. Exploring the benefits and challenges of health professionals\u2019 participation in online health communities: Emergence of (dis)empowerment processes and outcomes. Int J Med Inf. 2017;98:13\u201321.","journal-title":"Int J Med Inf"},{"key":"252_CR4","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/ijc.21683","volume":"118","author":"G Randi","year":"2006","unstructured":"Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591\u2013602.","journal-title":"Int J Cancer"},{"key":"252_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.12998\/wjcc.v3.i3.231","volume":"3","author":"AN Dwivedi","year":"2015","unstructured":"Dwivedi AN, Jain S, Dixit R. Gall bladder carcinoma: aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases. 2015;3:231\u201344.","journal-title":"World J Clin Cases"},{"key":"252_CR6","doi-asserted-by":"publisher","first-page":"13914","DOI":"10.18632\/oncotarget.4227","volume":"6","author":"Z Li","year":"2015","unstructured":"Li Z, Yu X, Shen J, Law PT, Chan MT, Wu WK. MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer. Oncotarget 2015;6:13914\u201321.","journal-title":"Oncotarget"},{"key":"252_CR7","doi-asserted-by":"crossref","unstructured":"He S, Wang G, Ni J, Zhuang J, Zhuang S, Wang G, et al. MicroRNA-511 inhibits cellular proliferation and invasion in colorectal cancer by directly targeting hepatoma-derived growth factor. Oncol Res. 2018;26:1355\u201363.","DOI":"10.3727\/096504018X15154094331876"},{"key":"252_CR8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.celrep.2016.04.034","volume":"15","author":"P Chaluvally-Raghavan","year":"2016","unstructured":"Chaluvally-Raghavan P, Jeong KJ, Pradeep S, Silva AM, Yu S, Liu W, et al. Direct upregulation of STAT3 by MicroRNA-551b-3p deregulates growth and metastasis of ovarian cancer. Cell Rep. 2016;15:1493\u2013504.","journal-title":"Cell Rep."},{"key":"252_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2018.01.032","volume":"418","author":"H Yuan","year":"2018","unstructured":"Yuan H, Chen Z, Bai S, Wei H, Wang Y. Ji R, et al. Molecular mechanisms of lncRNA SMARCC2\/miR-551b-3p\/TMPRSS4 axis in gastric cancer. Cancer Lett. 2018;418:84\u201396.","journal-title":"Cancer Lett"},{"key":"252_CR10","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1096\/fj.201700870RR","volume":"32","author":"M Tsachaki","year":"2018","unstructured":"Tsachaki M, Mladenovic N, Stambergova H, Birk J, Odermatt A. Hexose-6-phosphate dehydrogenase controls cancer cell proliferation and migration through pleiotropic effects on the unfolded-protein response, calcium homeostasis, and redox balance. FASEB J. 2018;32:2690\u2013705.","journal-title":"FASEB J"},{"key":"252_CR11","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1210\/en.2005-0117","volume":"146","author":"KN Hewitt","year":"2005","unstructured":"Hewitt KN, Walker EA, Stewart PM. Minireview: hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydrogenase type 1 activity. Endocrinology 2005;146:2539\u201343.","journal-title":"Endocrinology"},{"key":"252_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mce.2006.12.022","volume":"265-266","author":"PC White","year":"2007","unstructured":"White PC, Rogoff D, McMillan DR, Lavery GG. Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism. Mol Cell Endocrinol. 2007;265-266:89\u201392.","journal-title":"Mol Cell Endocrinol"},{"key":"252_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3892\/ol.2015.3179","volume":"10","author":"Z Chen","year":"2015","unstructured":"Chen Z, Liu X, Hu Z, Wang Y, Liu M, Liu X, et al. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. Oncol Lett. 2015;10:329\u201336.","journal-title":"Oncol Lett"},{"key":"252_CR14","unstructured":"Chen Z, Liu X, Liu M, Liu X, Jia J, Ji R, et al. [Expression of miR-551b-3p in gastric cancer cell lines and tissues and its clinical significance]. Zhonghua Zhong Liu Za Zhi. 2014;36:903\u20134."},{"key":"252_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.phrs.2018.02.022","volume":"131","author":"L Galbraith","year":"2018","unstructured":"Galbraith L, Leung HY, Ahmad I. Lipid pathway deregulation in advanced prostate cancer. Pharm Res. 2018;131:177\u201384.","journal-title":"Pharm Res"},{"key":"252_CR16","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/leu.2017.80","volume":"31","author":"T Yuan","year":"2017","unstructured":"Yuan T, Yang Y, Chen J, Li W, Li W, Zhang Q, et al. Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN\/Ikaros\/miR-26b mechanism reveals a critical targetable role for PIK3CD. Leukemia 2017;31:2355\u201364.","journal-title":"Leukemia"},{"key":"252_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.biopha.2016.11.090","volume":"88","author":"Q Bu","year":"2017","unstructured":"Bu Q, You F, Pan G, Yuan Q, Cui T, Hao L, et al. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD. Biomed Pharmacother. 2017;88:443\u20138.","journal-title":"Biomed Pharmacother"},{"key":"252_CR18","first-page":"1987","volume":"22","author":"HB Hu","year":"2018","unstructured":"Hu HB, Chen Q, Ding SQ. LncRNA LINC01116 competes with miR-145 for the regulation of ESR1 expression in breast cancer. Eur Rev Med Pharm Sci. 2018;22:1987\u201393.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"252_CR19","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/cam4.1310","volume":"7","author":"L Gu","year":"2018","unstructured":"Gu L, Lu LS, Zhou DL, Liu ZC. UCA1 promotes cell proliferation and invasion of gastric cancer by targeting CREB1 sponging to miR-590-3p. Cancer Med. 2018;7:1253\u201363.","journal-title":"Cancer Med"},{"key":"252_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","volume":"122","author":"CM Croce","year":"2005","unstructured":"Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005;122:6\u20137.","journal-title":"Cell"},{"key":"252_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0500-6","volume":"13","author":"G Liu","year":"2015","unstructured":"Liu G, Zhu J, Yu M, Cai C, Zhou Y, Yu M, et al. Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients. J Transl Med. 2015;13:144.","journal-title":"J Transl Med"},{"key":"252_CR22","first-page":"799","volume":"295","author":"JWG Zhang","year":"2016","unstructured":"Zhang JWG, Mao Q. Glutamate dehydrogenase (GDH) regulates bioenergetics and redox homeostasis in human glioma. Oncotarget 2016;295:799\u2013800.","journal-title":"Oncotarget"},{"key":"252_CR23","doi-asserted-by":"crossref","unstructured":"Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li C, et al. Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1alpha via miR-138. Open Biol. 2017;7160247.","DOI":"10.1098\/rsob.160247"},{"key":"252_CR24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/nm.3336","volume":"19","author":"WL Tam","year":"2013","unstructured":"Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013;19:1438\u201349.","journal-title":"Nat Med"},{"key":"252_CR25","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-0578-03","volume":"10","author":"S Nakajima","year":"2004","unstructured":"Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res. 2004;10:4125\u201333.","journal-title":"Clin Cancer Res"},{"key":"252_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1083\/jcb.147.3.631","volume":"147","author":"MT Nieman","year":"1999","unstructured":"Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol. 1999;147:631\u201344.","journal-title":"J Cell Biol"},{"key":"252_CR27","doi-asserted-by":"publisher","first-page":"45725","DOI":"10.18632\/oncotarget.17392","volume":"8","author":"G Song","year":"2017","unstructured":"Song G, Zhang H, Chen C, Gong L, Chen B, Zhao S, et al. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression. Oncotarget 2017;8:45725\u201335.","journal-title":"Oncotarget"},{"key":"252_CR28","first-page":"2106","volume":"9","author":"Z Su","year":"2017","unstructured":"Su Z, Liu G, Fang T, Zhang K, Yang S, Zhang H, et al. Expression and prognostic value of glutamate dehydrogenase in extrahepatic cholangiocarcinoma patients. Am J Transl Res. 2017;9:2106\u201318.","journal-title":"Am J Transl Res"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41417-020-00252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41417-020-00252-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41417-020-00252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:45Z","timestamp":1684617045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-00252-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,29]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1038\/s41417-020-00252-x","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,29]]},"assertion":[{"value":"28 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}